Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Packer

Showing results (41-50 of 326) with videos related to

Pageof 33
Sort By:
Journal of Cardiac Failure|June 23, 2001
Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failureM Packer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1987
Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failureM Packer
The American Journal of Cardiology|December 31, 1997
Effects of beta-adrenergic blockade on survival of patients with chronic heart failureM Packer
American Journal of Hypertension|March 21, 1998
Beta-blockade in heart failure. Basic concepts and clinical resultsM Packer
Chest|January 1, 1980
Is there a drug of choice for vasodilator therapy in patients with refractory heart failure?M Packer
Journal of the American College of Cardiology|November 1, 1983
Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticismM Packer
European Heart Journal|May 1, 1990
Diastolic function as a target of therapeutic interventions in chronic heart failureM Packer
European Heart Journal|April 1, 1996
Beta-blockade in the management of chronic heart failure. Another step in the conceptual evolution of a neurohormonal model of the diseaseM Packer
The American Journal of Cardiology|March 25, 1993
How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the diseaseM Packer
Journal of Internal Medicine|April 1, 1996
New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanismsM Packer
Pageof 33

Showing results (41-50 of 326) with videos related to

Sort By:
Pageof 33
Journal of Cardiac Failure|June 23, 2001
Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failureM Packer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1987
Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failureM Packer
The American Journal of Cardiology|December 31, 1997
Effects of beta-adrenergic blockade on survival of patients with chronic heart failureM Packer
American Journal of Hypertension|March 21, 1998
Beta-blockade in heart failure. Basic concepts and clinical resultsM Packer
Chest|January 1, 1980
Is there a drug of choice for vasodilator therapy in patients with refractory heart failure?M Packer
Journal of the American College of Cardiology|November 1, 1983
Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticismM Packer
European Heart Journal|May 1, 1990
Diastolic function as a target of therapeutic interventions in chronic heart failureM Packer
European Heart Journal|April 1, 1996
Beta-blockade in the management of chronic heart failure. Another step in the conceptual evolution of a neurohormonal model of the diseaseM Packer
The American Journal of Cardiology|March 25, 1993
How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the diseaseM Packer
Journal of Internal Medicine|April 1, 1996
New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanismsM Packer
Pageof 33